Episode 107.0 – Angioedema - a podcast by Core EM

from 2017-07-24T11:00:03

:: ::















Prompted by the recent CAMEO trial publication on icatibant, we dive into angioedema with a focus on airway management.







https://media.blubrry.com/coreem/content.blubrry.com/coreem/Episode_107_0_Final_Cut.m4a







Download





Leave a Comment











Tags: , , ,











Show Notes

Take Home Points



Airway management is paramount, expect a challenging intubation and consider controlling the airway early

When controlling the airway, consider an awake approach and fiberoptics if available. Always be prepared for the can’t intubate, can’t oxygenate scenario with a double set up.

If the patient has urticaria and pruritus, the process is likely histamine mediated and will respond to typical anaphylaxis treatment

Finally, observe the patient for progression of swelling and don’t forget to stop the inciting medication



Read More

Core EM: Angioedema

EMCrit: Podcast 145 – Awake Intubation Lecture from SMACC

ERCast: Angioedema

REBEL EM: Icatibant Doesn’t Improve Outcomes in ACE-I Induced Angioedema

The SGEM: Icatibant Bites the Dust – For ACE-I Induced Angioedema





Read More

Further episodes of Core EM - Emergency Medicine Podcast

Further podcasts by Core EM

Website of Core EM